Anzeige
Mehr »
Mittwoch, 01.10.2025 - Börsentäglich über 12.000 News
Globaler Gamechanger: CiTech expandiert in Europa - neue Chancen für Investoren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40YEM | ISIN: US19207A2078 | Ticker-Symbol:
NASDAQ
30.09.25 | 21:57
17,230 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COEPTIS THERAPEUTICS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
COEPTIS THERAPEUTICS HOLDINGS INC 5-Tage-Chart

Aktuelle News zur COEPTIS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:14Coeptis Therapeutics: Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage144BRISTOL, TN / ACCESS Newswire / October 1, 2025 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) today announced that The Vanderbilt Report has published coverage of the company following its recent...
► Artikel lesen
23.09.Vanderbilt Report and Coeptis Therapeutics: Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating2
12.09.Coeptis Therapeutics Holdings, Inc. - S-4/A, Registration of securities, business combinations1
14.08.Coeptis Therapeutics Holdings, Inc. - 10-Q, Quarterly Report2
09.08.Coeptis Therapeutics Holdings, Inc. - S-4/A, Registration of securities, business combinations-
22.07.Coeptis Therapeutics: Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd1
COEPTIS THERAPEUTICS Aktie jetzt für 0€ handeln
26.06.Coeptis Therapeutics: Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared2
26.06.Coeptis Therapeutics Holdings, Inc. - S-4, Registration of securities, business combinations-
03.06.Coeptis Therapeutics Holdings, Inc. - 10-K/A, Annual Report1
28.05.Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology1
14.05.Coeptis Therapeutics Holdings, Inc. - 10-Q, Quarterly Report2
26.04.Coeptis Therapeutics Holdings, Inc. - 8-K, Current Report-
25.04.Coeptis Flops on Merger with Z Squared7
25.04.Coeptis, Dogecoin Mining Firm Z Squared To Merge; To Spin Out Biopharma Unit; Stock Down1
25.04.Coeptis Therapeutics, Z Squared announce merger agreement1
25.04.Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement232WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative...
► Artikel lesen
17.04.COEPTIS kündigt strategischen Technologie-Hub in Indien an1
17.04.COEPTIS announces strategic tech hub in India1
17.04.Coeptis Therapeutics: COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology3
04.04.Coeptis Therapeutics Holdings, Inc. - S-1/A, General form for registration of securities2
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1